NL-OMON54621
Recruiting
Not Applicable
Prospective Bladder Cancer Infrastructure - An infrastructure for observational and interventional bladder cancer research - ProBCI
Stichting Prospectieve Blaaskanker Infrastructuur0 sites3,500 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- bladder cancer
- Sponsor
- Stichting Prospectieve Blaaskanker Infrastructuur
- Enrollment
- 3500
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histologically proven bladder cancer (high\-risk non\-muscle\-invasive /
- •muscle\-invasive / metastatic)
- •Written informed consent
Exclusion Criteria
- •Bladder cancer stage Ta
- •Inable to read and understand informed consent procedure
- •No inhabitant of the Netherlands
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Prospective Bladder Cancer Infrastructure (ProBCI)Bladder CancerNCT04503577Prospective Bladder Cancer Infrastructure Foundation3,600
Recruiting
Not Applicable
BlaaskankerZorg In BeeldBladder cancerNL-OMON26633Dutch Cancer Society (KWF Kankerbestrijding)6,500
Not yet recruiting
Not Applicable
Xpert Bladder Cancer Monitorto Predict Need for 2nd TURBMoniTURB Trial”C67Malignant neoplasm of bladderDRKS00014974Cepheid Europe600
Not yet recruiting
Not Applicable
Bladder cancer sentinel node mapping using ICG-99mTc-nanocolloidBladder cancerBladder carcinomaNL-OMON21640The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands30
Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220